摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,6R,7S,8S,12R,13S,15S)-15-Azido-12,13-epoxy-4,4,6,8,12,16-hexamethyl-7-hydroxy-17-(2-methyl-4-thiazolyl)-5-oxo-16-heptadecenoic acid | 219990-18-8

中文名称
——
中文别名
——
英文名称
(3S,6R,7S,8S,12R,13S,15S)-15-Azido-12,13-epoxy-4,4,6,8,12,16-hexamethyl-7-hydroxy-17-(2-methyl-4-thiazolyl)-5-oxo-16-heptadecenoic acid
英文别名
(6R,7S,8S)-11-[(2R,3S)-3-[(E,2S)-2-azido-3-methyl-4-(2-methyl-1,3-thiazol-4-yl)but-3-enyl]-2-methyloxiran-2-yl]-7-hydroxy-4,4,6,8-tetramethyl-5-oxoundecanoic acid
(3S,6R,7S,8S,12R,13S,15S)-15-Azido-12,13-epoxy-4,4,6,8,12,16-hexamethyl-7-hydroxy-17-(2-methyl-4-thiazolyl)-5-oxo-16-heptadecenoic acid化学式
CAS
219990-18-8
化学式
C27H42N4O5S
mdl
——
分子量
534.72
InChiKey
GQWFBHBONODVDK-BIOQQELPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    37
  • 可旋转键数:
    16
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.74
  • 拓扑面积:
    143
  • 氢给体数:
    2
  • 氢受体数:
    9

文献信息

  • EPOTHILONE DERIVATIVES
    申请人:Vite D. Gregory
    公开号:US20070255055A1
    公开(公告)日:2007-11-01
    The present invention relates to compounds of the formula Q is selected from the group consisting of G is selected from the group consisting of alkyl, substituted alkyl, substituted or unsubstituted aryl, heterocyclo, W is O or NR 15 ; X is O or H,H; Y is selected from the group consisting of O; H,OR 16 ; OR 17 ,OR 17 ; NOR 18 ; H,NOR 19 ; H,NR 20 R 21 ; H,H; or CHR 22 ; OR 17 OR 17 can be a cyclic ketal; Z 1 and Z 2 are selected from the group consisting of CH 2 , O, NR 23 , S, or SO 2 , wherein only one of Z and Z 2 is a heteroatom; B 1 and B 2 are selected from the group consisting of OR 24 , or OCOR 25 , or O 2 CNR 26 R 27 ; when B 1 is H and Y is OH, H they can form a six-membered ring ketal or acetal; D is selected from the group consisting of NR 28 R 29 , NR 30 COR 31 or saturated heterocycle; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 13 , R 14 , R 18 , R 19 , R 20 , R 21 , R 22 , R 26 , and R 27 are selected from the group H, alkyl, substituted alkyl, or aryl and when R 1 and R 2 are alkyl can be joined to form a cycloalkyl; R 3 and R 4 are alkyl can be joined to form a cycloalkyl; R 9 , R 10 , R 16 , R 17 , R 24 , R 25 , and R 31 are selected from the group H, alkyl, or substituted alkyl; R 8 , R 11 , R 12 , R 28 , R 30 , R 32 , R 33 , and R 30 are selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl, or heterocyclo; R 15 , R 23 and R 29 are selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl, heterocyclo, R 32 C═O, R 33 SO 2 , hydroxy, O-alkyl or O-substituted alkyl, the pharmaceutically acceptable salts thereof and any hydrates, solvates or geometric, optical and stereoisomers thereof, with the proviso that compounds wherein W and X are both O; and R 1 , R 2 , R 7 , are H; and R 3 , R 4 , R 6 , are methyl; and R 8 , is H or methyl; and Z 1 , and Z 2 , are CH 2 ; and G is 1-methyl-2-(substituted-4-thiazolyl)ethenyl; and Q is as defined above are excluded.
    本发明涉及以下化合物的公式:其中Q选自G选自烷基,取代烷基,取代或未取代芳基,杂环烷基,W为O或NR15;X为O或H;Y选自O,H,OR16,OR17,NOR18,H,NOR19,H,NR20R21,H,H或CHR22;OR17OR17可以是环状缩酮;Z1和Z2选自CH2,O,NR23,S或SO2,其中仅Z和Z2中的一个为杂原子;B1和B2选自OR24,或OCOR25,或O2CNR26R27;当B1为H且Y为OH时,它们可以形成六元环缩酮缩醛;D选自NR28R29,NR30COR31或饱和杂环;R1,R2,R3,R4,R5,R6,R7,R13,R14,R18,R19,R20,R21,R22,R26和R27选自H,烷基,取代烷基或芳基,当R1和R2为烷基时,可以连接成环烷基;R3和R4为烷基时,可以连接成环烷基;R9,R10,R16,R17,R24,R25和R31选自H,烷基或取代烷基;R8,R11,R12,R28,R30,R32,R33和R30选自H,烷基,取代烷基,芳基,取代芳基,环烷基或杂环烷基;R15,R23和R29选自H,烷基,取代烷基,芳基,取代芳基,环烷基,杂环烷基,R32C═O,R33SO2,羟基,O-烷基或O-取代烷基,其药学上可接受的盐和任何合物,溶剂化合物或其几何,光学和立体异构体,但其中W和X都是O;并且R1,R2,R7为H;并且R3,R4,R6为甲基;并且R8为H或甲基;并且Z1和Z2为 ;并且G为1-甲基-2-(取代-4-噻唑基)乙烯基;并且Q如上所定义被排除在外。
  • Epothilone derivatives
    申请人:Vite D. Gregory
    公开号:US20060287371A1
    公开(公告)日:2006-12-21
    The present invention relates to compounds of the formula in which the variables G, W, Q, X, Y, B 1 , B 2 , Z 1 , Z 2 , and R 1 -R 7 are as defined herein, methods for the preparation of the derivatives and intermediates thereof.
    本发明涉及公式中的化合物,其中变量G、W、Q、X、Y、B1、B2、Z1、Z2和R1-R7的定义如本文所述,以及其衍生物和中间体的制备方法。
  • [EN] A PROCESS FOR THE REDUCTION OF OXIRANYL EPOTHILONES TO OLEFINIC EPOTHILONES<br/>[FR] PROCEDE DE REDUCTION D'EPOTHILONES D'OXIRANYLE EN EPOTHILONES OLEFINIQUES
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2000071521A1
    公开(公告)日:2000-11-30
    The invention as claimed is directed to a process for making an epothilone having structures (II) or (IV) from ones having an oxiranyl moiety, by reacting a compound having the latter structure with a metal or metal-assisted reagent. Said metal or metal-assisted reagent is selected from the group consisting of a) reactive metallocenes; b) [N2C(CO2Me)2, cat Rh2,(OAC)4]; c) [N2C(CO2Me)2, cat[(n-C7H15CO2)2 Rh]2]; d) [Zn-Cu, EtOH]; e) [Mg(Hg), MgBr]; f) Cr; g) [FeCl3, n-BuLi]; h) [TiCl3, LiAlH4]; i) [TiCl4, Zn]; j) [WCl6, LiAlH4]; k) [NbCl5, NaAlH4]; l) [VCl3,Zn] and m) [WCl6, n-BuLi].
    所述发明涉及一种从具有环氧丙烷基团的化合物制备结构为(II)或(IV)的环普鲁霉素的方法,通过将具有后一种结构的化合物与属或属辅助试剂反应。所述属或属辅助试剂选自以下组合:a)反应性属茂;b)[N2C(CO2Me)2,猫Rh2,(OAC)4];c)[N2C(CO2Me)2,猫[(n-C7H15CO2)2Rh]2];d)[Zn-Cu,EtOH];e)[Mg(Hg),MgBr];f)Cr;g)[FeCl3,n-BuLi];h)[TiCl3,LiAlH4];i)[TiCl4,Zn];j)[WCl6,LiAlH4];k)[NbCl5,NaAlH4];l)[VCl3,Zn]和m)[WCl6,n-BuLi]。
  • A PROCESS FOR THE REDUCTION OF OXIRANYL EPOTHILONES TO OLEFINIC EPOTHILONES
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP1178968A1
    公开(公告)日:2002-02-13
  • EP1178968A4
    申请人:——
    公开号:EP1178968A4
    公开(公告)日:2002-06-19
查看更多

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (1aR,4E,7aS,8R,10aS,10bS)-8-[((二甲基氨基)甲基]-2,3,6,7,7a,8,10a,10b-八氢-1a,5-二甲基-氧杂壬酸[9,10]环癸[1,2-b]呋喃-9(1aH)-酮 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸溴乙酯 齐墩果酸二甲胺基乙酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 齐墩果-12-烯-28-酸,3,7-二羰基-(9CI) 齐墩果-12-烯-28-酸,3,21,29-三羟基-,g-内酯,(3b,20b,21b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸